Article Versions Notes

Tan KS, Wang D, Lu Z, Zhang Y, Li S, Lin Y, Tan W. CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production. International Journal of Molecular Sciences. 2021; 22(19):10806. https://doi.org/10.3390/ijms221910806

Tan, Keai Sinn, Dongfang Wang, Ziqiang Lu, Yihan Zhang, Sixu Li, Yue Lin, and Wen Tan. 2021. "CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production" International Journal of Molecular Sciences 22, no. 19: 10806. https://doi.org/10.3390/ijms221910806

Tan, K. S., Wang, D., Lu, Z., Zhang, Y., Li, S., Lin, Y., & Tan, W. (2021). CNPase, a 2′,3′-Cyclic-nucleotide 3′-phosphodiesterase, as a Therapeutic Target to Attenuate Cardiac Hypertrophy by Enhancing Mitochondrial Energy Production. International Journal of Molecular Sciences, 22(19), 10806. https://doi.org/10.3390/ijms221910806